Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Françoise Van Bambeke

Showing results (1-10 of 210) with videos related to

Pageof 21
Sort By:
Future Microbiology|June 30, 2015
Delafloxacin, a non-zwitterionic fluoroquinolone in Phase III of clinical development: evaluation of its pharmacology, pharmacokinetics, pharmacodynamics and clinical efficacyFrançoise Van Bambeke
Current Drug Targets|November 3, 2010
ABC transporters: role in modulation of drug pharmacokinetics and in physiopathology and therapeutic perspectivesFrançoise Van Bambeke
Current Opinion in Investigational Drugs (London, England : 2000)|September 8, 2006
Glycopeptides and glycodepsipeptides in clinical development: a comparative review of their antibacterial spectrum, pharmacokinetics and clinical efficacyFrançoise Van Bambeke
Drugs|November 26, 2015
Lipoglycopeptide Antibacterial Agents in Gram-Positive Infections: A Comparative ReviewFrançoise Van Bambeke
Current Opinion in Pharmacology|September 8, 2004
Glycopeptides in clinical development: pharmacological profile and clinical perspectivesFrançoise Van Bambeke
Annals of Medicine|July 25, 2014
Renaissance of antibiotics against difficult infections: Focus on oritavancin and new ketolides and quinolonesFrançoise Van Bambeke
Current Drug Targets|November 3, 2010
ABC multidrug transporters: target for modulation of drug pharmacokinetics and drug-drug interactionsBéatrice Marquez, Françoise Van Bambeke
Expert Review of Anti-Infective Therapy|January 5, 2024
Understanding <i>Staphylococcus aureus</i> internalisation and induction of antimicrobial toleranceFrédéric Goormaghtigh, Françoise Van Bambeke
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 27, 2015
Editorial Commentary: Colistin and a New Paradigm in Drug DevelopmentFrançoise Van Bambeke, Paul M Tulkens
Drug Safety|May 8, 2009
Safety profile of the respiratory fluoroquinolone moxifloxacin: comparison with other fluoroquinolones and other antibacterial classesFrançoise Van Bambeke, Paul M Tulkens
Pageof 21

Showing results (1-10 of 210) with videos related to

Sort By:
Pageof 21
Future Microbiology|June 30, 2015
Delafloxacin, a non-zwitterionic fluoroquinolone in Phase III of clinical development: evaluation of its pharmacology, pharmacokinetics, pharmacodynamics and clinical efficacyFrançoise Van Bambeke
Current Drug Targets|November 3, 2010
ABC transporters: role in modulation of drug pharmacokinetics and in physiopathology and therapeutic perspectivesFrançoise Van Bambeke
Current Opinion in Investigational Drugs (London, England : 2000)|September 8, 2006
Glycopeptides and glycodepsipeptides in clinical development: a comparative review of their antibacterial spectrum, pharmacokinetics and clinical efficacyFrançoise Van Bambeke
Drugs|November 26, 2015
Lipoglycopeptide Antibacterial Agents in Gram-Positive Infections: A Comparative ReviewFrançoise Van Bambeke
Current Opinion in Pharmacology|September 8, 2004
Glycopeptides in clinical development: pharmacological profile and clinical perspectivesFrançoise Van Bambeke
Annals of Medicine|July 25, 2014
Renaissance of antibiotics against difficult infections: Focus on oritavancin and new ketolides and quinolonesFrançoise Van Bambeke
Current Drug Targets|November 3, 2010
ABC multidrug transporters: target for modulation of drug pharmacokinetics and drug-drug interactionsBéatrice Marquez, Françoise Van Bambeke
Expert Review of Anti-Infective Therapy|January 5, 2024
Understanding <i>Staphylococcus aureus</i> internalisation and induction of antimicrobial toleranceFrédéric Goormaghtigh, Françoise Van Bambeke
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 27, 2015
Editorial Commentary: Colistin and a New Paradigm in Drug DevelopmentFrançoise Van Bambeke, Paul M Tulkens
Drug Safety|May 8, 2009
Safety profile of the respiratory fluoroquinolone moxifloxacin: comparison with other fluoroquinolones and other antibacterial classesFrançoise Van Bambeke, Paul M Tulkens
Pageof 21